Back |
home / stock / ortx / ortx message board
Subject | By | Source | When |
---|---|---|---|
$7.50 Feb Calls for 1.25 are a steal... | MWM | investorshub | 01/06/2021 3:58:34 PM |
https://www.orchard-tx.com/about/our-story/ | MWM | investorshub | 01/06/2021 3:58:18 PM |
$ORTX I like this volume here. Added a | MWM | investorshub | 01/06/2021 3:58:02 PM |
In some stock and Calls | MWM | investorshub | 01/06/2021 3:15:57 PM |
Orchard Therapeutics Receives EC Approval for Libmeldy for | realfast95 | investorshub | 12/21/2020 1:18:04 PM |
This is not Libmeldy | realfast95 | investorshub | 10/30/2020 8:53:18 PM |
Orchard Therapeutics Gets CHMP Approval for Libmeldy | realfast95 | investorshub | 10/16/2020 11:13:14 AM |
Orchard Therapeutics (Nasdaq:$ ORTX), a global gene therapy | realfast95 | investorshub | 09/28/2020 11:07:05 AM |
$230M cash & burning $38M/Q | realfast95 | investorshub | 09/01/2020 11:59:14 AM |
Orchard Therapeutics Announces Additional Interim Results from Proof-of-Concept | realfast95 | investorshub | 09/01/2020 11:58:10 AM |
News, Short Squeeze, Breakout and More Instantly...
Orchard Therapeutics plc Company Name:
ORTX Stock Symbol:
NASDAQ Market:
TOKYO, LONDON and BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating ...
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., Ph.D., co-founder and chief executive officer, ...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...